Held on 22 November 2017
Kilpest India announced that the Board of its subsidiary, 3B BlackBio Biotech India has approved the preferential issue of up to 4 lakh warrants convertible into equity shares of Rs 10 each at a price of Rs 100 each to promoters and non promoter entities subject to approval of members.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
